UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

______________

 FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of Earliest Event Reported): February 8, 2019

VENTAS, INC.

(Exact Name of Registrant as Specified in Its Charter)

 [DATA_TABLE_REMOVED]  

 353 N. Clark Street, Suite 3300, Chicago, Illinois    

 60654    

  (Address of Principal Executive Offices)   (Zip Code)     

 Registrant’s Telephone Number, Including Area Code: (877) 483-6827

Not Applicable

Former Name or Former Address, if Changed Since Last Report  

 Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the Registrant under any of the following provisions:  

 ⃞ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

⃞ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

⃞ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

⃞ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).  

 Emerging growth company ⃞  

 If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ⃞  

 Item 2.02.    

 Results of Operations and Financial Condition.      

 On February 8, 2019, Ventas, Inc. (the “Company”) issued a press release announcing its results of operations for the year and quarter ended December 31, 2018. A copy of the press release is furnished herewith as Exhibit 99.1 and incorporated in this Item 2.02 by reference.  

 The information in this Item 2.02, including Exhibit 99.1, shall not be deemed filed with the U.S. Securities and Exchange Commission for purposes of Section 18 of the Securities Exchange Act of 1934, as amended. The information in this Current Report shall not be incorporated by reference into any filing of the Company regardless of general incorporation language in such filing.  

  Item 7.01.   

 Regulation FD Disclosure.      

 On February 8, 2019, the Company issued a press release announcing its expected university-based research and innovation development pipeline. A copy of the press release is furnished herewith as Exhibit 99.2 and incorporated in this Item 7.01 by reference.  

 The information in this Item 7.01, including Exhibit 99.2, shall not be deemed filed with the U.S. Securities and Exchange Commission for purposes of Section 18 of the Securities Exchange Act of 1934, as amended. The information in this Current Report shall not be incorporated by reference into any filing of the Company regardless of general incorporation language in such filing.  

 Item 9.01.    

 Financial Statements and Exhibits.      

 [DATA_TABLE_REMOVED]  

 [DATA_TABLE_REMOVED]  

 SIGNATURES  

 Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.  

 [DATA_TABLE_REMOVED]